ENTX Entera Bio Ltd.
Fundamentals / CIK 0001638097 / USDEntera Bio Ltd. reported $0 in revenue and a net loss of $29.43M for the trailing twelve months ended September 30, 2026 (down 76.8% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ENTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 -76.8% YoY
-
Operating Income TTM-$18.41M Operating profit
-
Net Income TTM-$29.43M GAAP bottom line
-
Diluted EPS TTM-$0.20 Split-adjusted
-
Free Cash Flow TTM-$15.84M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$265.9M Total debt: $397K
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42K | $181K | $0 | $134K | $571K | $365K | $236K | $500K | -- | -- |
| Cost of Revenue | $42K | $172K | $0 | $101K | $373K | $300K | $210K | -- | -- | -- |
| Gross Profit | $0 | $9.0K | $0 | $33K | $198K | $65K | $26K | -- | -- | -- |
| Research & Development | $6.00M | $4.50M | $4.51M | $5.85M | $6.77M | $6.38M | $7.20M | $8.52M | $2.77M | $2.65M |
| Selling, General & Admin | $398K | $340K | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $11.53M | $9.59M | $8.89M | $13.05M | $12.41M | $11.23M | -- | -- | -- | -- |
| Operating Income | -$11.53M | -$9.59M | -$8.89M | -$13.02M | -$12.22M | -$11.17M | -$11.45M | -$10.86M | -$11.34M | -$5.37M |
| EBITDA | -$11.50M | -$9.54M | -$8.84M | -$12.95M | -$12.16M | -$11.11M | -$11.22M | -$10.81M | -$11.30M | -$5.33M |
| Income Before Tax | -$11.44M | -$9.53M | -$8.86M | -$12.93M | -$12.25M | -$11.20M | -$10.79M | -$10.30M | -- | -- |
| Income Tax Expense | $0 | $14K | $29K | $137K | -$59K | $20K | -- | -- | -- | -- |
| Net Income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | -$10.79M | -$10.30M | -$11.20M | -$1.20M |
| Basic EPS | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.30 | $2.49 | $0.27 |
| Diluted EPS | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.31 | $2.49 | $0.78 |
| Basic Shares Outstanding | 46.2M | 37.7M | 29.0M | 28.8M | 26.1M | 18.4M | 12.1M | 8.0M | 4.5M | 4.5M |
| Diluted Shares Outstanding | 46.2M | 37.7M | 29.0M | 28.8M | 26.1M | 18.4M | 12.1M | 8.0M | 4.5M | 6.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $42K | $82K |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $42K | $82K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | $4.92M | $3.20M | $2.25M | $1.72M | $1.64M | $1.52M | $1.12M | $1.20M |
| Selling, General & Admin | $157K | $124K | $128K | $54K | $118K | $103K | $123K | -- |
| Total Operating Expenses | $7.26M | $4.56M | $3.54M | $3.04M | $3.26M | $2.67M | $2.56M | $2.34M |
| Operating Income | -$7.26M | -$4.56M | -$3.54M | -$3.04M | -$3.26M | -$2.67M | -$2.56M | -$2.34M |
| EBITDA | -$7.26M | -$4.55M | -$3.53M | -$3.04M | -$3.25M | -$2.66M | -$2.56M | -$2.33M |
| Net Income | -$15.60M | -$7.31M | -$3.50M | -$3.02M | -$3.20M | -$2.66M | -$2.57M | -$2.36M |
| Basic EPS | $0.11 | $0.14 | $0.07 | -- | $0.07 | $0.06 | $0.06 | -- |
| Diluted EPS | $0.11 | $0.14 | $0.07 | -- | $0.07 | $0.06 | $0.06 | -- |
| Basic Shares Outstanding | 145.1M | 50.5M | 47.8M | -- | 47.1M | 46.8M | 43.4M | -- |
| Diluted Shares Outstanding | 145.1M | 50.5M | 47.8M | -- | 47.1M | 46.8M | 43.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | $8.59M | $15.19M | $7.51M | $11.75M |
| Cash & Short-Term Investments | $7.11M | $8.66M | $11.02M | $12.31M | $24.89M | $8.59M | $15.19M | $7.51M | $11.75M |
| Accounts Receivable, Net | $0 | $126K | $0 | $246K | $183K | $255K | $278K | $725K | -- |
| Other Current Assets | $107K | $186K | $238K | $294K | $254K | $261K | $97K | $90K | $159K |
| Total Current Assets | $15.30M | $8.97M | $11.26M | $12.85M | $25.33M | $9.11M | $15.64M | $12.47M | $12.42M |
| Property, Plant & Equipment, Net | $134K | $57K | $100K | $139K | $156K | $192K | $202K | $224K | $207K |
| Intangible Assets | -- | -- | -- | -- | -- | $605K | $605K | $651K | $654K |
| Total Non-Current Assets | $695K | $418K | $508K | $278K | $658K | $613K | $1.07M | $875K | $861K |
| Total Assets | $15.99M | $9.39M | $11.77M | $13.13M | $25.99M | $9.72M | $16.70M | $13.34M | $13.28M |
| Accounts Payable | $448K | $132K | $83K | $17K | $166K | $164K | $334K | $473K | $596K |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $15K | $158K | $267K | $225K | -- |
| Total Current Liabilities | $2.20M | $1.18M | $1.09M | $1.34M | $3.16M | $1.84M | $4.59M | $3.16M | $2.02M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | -- | $3.89M |
| Other Non-Current Liabilities | $393K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $689K | $134K | $288K | $32K | $261K | $371K | $192K | $65K | $42.82M |
| Total Liabilities | $2.89M | $1.31M | $1.38M | $1.37M | $3.42M | $2.21M | $4.78M | $3.23M | $44.84M |
| Total Debt (incl. Leases) | $490K | $272K | $390K | $91K | $302K | $432K | $299K | -- | $3.89M |
| Common Stock | $1.0K | $1.0K | $1.0K | -- | -- | -- | -- | -- | -- |
| Retained Earnings | -$125.4M | -$113.9M | -$104.4M | -$95.50M | -$82.43M | -$70.24M | -$62.91M | -$52.12M | -$41.81M |
| Accumulated Other Comp. Income | $41K | $41K | $41K | $41K | $41K | $41K | $11.40M | $13.02M | $7.36M |
| Total Stockholders' Equity | $13.10M | $8.08M | $10.39M | $11.75M | $22.57M | $7.51M | $13.77M | $10.12M | -$31.56M |
| Total Equity | $13.10M | $8.08M | $10.39M | $11.75M | $22.57M | $7.51M | $13.77M | $10.12M | -$31.56M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $265.9M | $11.31M | $4.14M | $7.11M | $8.57M | $10.86M | $12.57M | $8.66M |
| Cash & Short-Term Investments | $265.9M | $11.31M | $4.14M | $7.11M | $8.57M | $10.86M | $12.57M | $8.66M |
| Accounts Receivable, Net | -- | -- | -- | $0 | $0 | $0 | $126K | $126K |
| Other Current Assets | $182K | $144K | $256K | $107K | $262K | $192K | $165K | $186K |
| Total Current Assets | $276.5M | $18.90M | $12.49M | $15.30M | $17.01M | $19.31M | $21.22M | $8.97M |
| Property, Plant & Equipment, Net | $133K | $121K | $127K | $134K | $114K | $79K | $57K | $57K |
| Total Non-Current Assets | $575K | $584K | $636K | $695K | $400K | $356K | $382K | $418K |
| Total Assets | $277.0M | $19.48M | $13.13M | $15.99M | $17.41M | $19.67M | $21.60M | $9.39M |
| Accounts Payable | $406K | $575K | $274K | $448K | $216K | $383K | $134K | $132K |
| Total Current Liabilities | $2.15M | $2.10M | $1.58M | $2.20M | $1.57M | $1.84M | $1.62M | $1.18M |
| Other Non-Current Liabilities | -- | -- | -- | $393K | -- | -- | -- | $0 |
| Total Non-Current Liabilities | $605K | $10.11M | $866K | $689K | $602K | $567K | $598K | $134K |
| Total Liabilities | $2.76M | $12.21M | $2.44M | $2.89M | $2.17M | $2.41M | $2.22M | $1.31M |
| Total Debt (incl. Leases) | $397K | $425K | $448K | $490K | $211K | $203K | $220K | $272K |
| Common Stock | $5.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$151.8M | -$136.2M | -$128.9M | -$125.4M | -$122.3M | -$119.2M | -$116.5M | -$113.9M |
| Accumulated Other Comp. Income | $41K | $41K | $41K | $41K | $41K | $41K | $41K | $41K |
| Total Stockholders' Equity | $274.3M | $7.27M | $10.69M | $13.10M | $15.23M | $17.26M | $19.38M | $8.08M |
| Total Equity | $274.3M | $7.27M | $10.69M | $13.10M | $15.23M | $17.26M | $19.38M | $8.08M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.44M | -$9.54M | -$8.89M | -$13.07M | -$12.19M | -$11.22M | -$10.79M | -$10.30M | -$11.20M | -$1.20M |
| Depreciation & Amortization | $30K | $46K | $56K | $64K | $53K | $63K | $238K | $54K | $43K | $35K |
| Stock-Based Compensation | $2.75M | $2.56M | $1.69M | $2.25M | $1.86M | $901K | $1.48M | $1.23M | $4.88M | $1.49M |
| Change in Receivables | $126K | -$126K | $246K | -$63K | $72K | $23K | $447K | -$725K | -- | -- |
| Change in Payables | $316K | $49K | $66K | -$149K | $2.0K | -$170K | -$139K | -$123K | $543K | -$298K |
| Operating Cash Flow | -$7.37M | -$6.82M | -$7.31M | -$12.50M | -$9.06M | -$10.56M | -$8.92M | -$9.80M | -$4.53M | -$3.14M |
| Capital Expenditure | -$107K | -$3.0K | -$17K | -$47K | -$17K | -$53K | -$40K | -$68K | -$51K | -$41K |
| Free Cash Flow | -$7.48M | -$6.82M | -$7.33M | -$12.55M | -$9.08M | -$10.61M | -$8.96M | -$9.86M | -$4.58M | -$3.18M |
| Investing Cash Flow | -$107K | -$3.0K | -$17K | -$102K | -$17K | -$53K | $3.95M | -$4.07M | $1.00M | -$1.12M |
| Common Stock Issued | $6.25M | $3.96M | $5.0K | $0 | $21.80M | $3.19M | -- | -- | $12.09M | -- |
| Financing Cash Flow | $13.71M | $4.48M | $6.04M | $13K | $25.38M | $4.05M | $12.65M | $9.62M | $11.11M | $7.22M |
| Net Change in Cash | $6.20M | -$2.35M | -$1.29M | -$12.59M | $16.30M | -$6.56M | $7.68M | -$4.24M | $7.58M | $2.96M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$15.60M | -$7.31M | -$3.50M | -$3.02M | -$3.20M | -$2.66M | -$2.57M | -$2.36M |
| Depreciation & Amortization | $9.0K | $9.0K | $7.0K | $7.0K | $8.0K | $7.0K | $8.0K | $11K |
| Stock-Based Compensation | $1.82M | $624K | $672K | $710K | $927K | $509K | $604K | $566K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $7.0K |
| Change in Payables | -$169K | $301K | -$174K | $232K | -$167K | $249K | $2.0K | -$52K |
| Operating Cash Flow | -$7.40M | -$3.46M | -$3.09M | -$1.83M | -$2.50M | -$1.63M | -$1.40M | -$1.47M |
| Capital Expenditure | -$21K | -$3.0K | $0 | -$27K | -$43K | -$29K | -$8.0K | -$3.0K |
| Free Cash Flow | -$7.42M | -$3.47M | -$3.09M | -$1.86M | -$2.54M | -$1.66M | -$1.41M | -$1.47M |
| Investing Cash Flow | -$21K | -$3.0K | $0 | -$27K | -$43K | -$29K | -$8.0K | -$3.0K |
| Common Stock Issued | $0 | $0 | $0 | $0 | $71K | $0 | $6.18M | $3.34M |
| Financing Cash Flow | $261.4M | $9.96M | $130K | $174K | $250K | -$51K | $13.34M | $3.22M |
| Net Change in Cash | $254.0M | $6.49M | -$2.96M | -- | -$2.29M | -$1.71M | $11.93M | $1.75M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.0% | 5.0% | -- | 24.6% | 34.7% | 17.8% | 11.0% | -- | -- | -- |
| Operating Margin | -27450.0% | -5295.6% | -- | -9714.2% | -2139.6% | -3059.7% | -4853.4% | -2172.2% | -- | -- |
| Net Profit Margin | -27235.7% | -5271.3% | -- | -9754.5% | -2134.3% | -3072.9% | -4574.2% | -2060.8% | -- | -- |
| Return on Equity (ROE) | -87.3% | -118.1% | -85.6% | -111.2% | -54.0% | -149.3% | -78.4% | -101.9% | -- | -- |
| Return on Assets (ROA) | -71.5% | -101.6% | -75.6% | -99.6% | -46.9% | -115.4% | -64.6% | -77.2% | -84.3% | -- |
| Current Ratio | 6.94x | 7.63x | 10.32x | 9.58x | 8.01x | 4.95x | 3.41x | 3.94x | 6.15x | -- |
| Quick Ratio | 3.23x | 7.47x | 10.10x | 9.36x | 7.93x | 4.81x | 3.37x | 2.60x | 5.81x | -- |
| Debt to Equity | 0.04x | 0.03x | 0.04x | 0.01x | 0.01x | 0.06x | 0.02x | -- | -- | -- |
| Revenue Growth (YoY) | -76.8% | -- | -100.0% | -76.5% | +56.4% | +54.7% | -52.8% | -- | -- | -- |
| Gross Profit Growth (YoY) | -100.0% | -- | -100.0% | -83.3% | +204.6% | +150.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 0.0% | -19.4% | -31.1% | -4.3% | -29.9% | -24.7% | -31.5% | -47.8% | +822.2% | -- |
| 5Y Revenue / Share Growth | -95.4% | -75.3% | -100.0% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 0.0% | 0.0% | 0.0% | 4.0% | 5.0% |
| Operating Margin | -- | -- | -- | -27450.0% | -8729.0% | -6378.9% | -4522.9% | -5295.6% |
| Net Profit Margin | -- | -- | -- | -27235.7% | -8694.4% | -6386.7% | -4525.1% | -5271.3% |
| Return on Equity (ROE) | -10.7% | -234.4% | -115.8% | -87.3% | -70.8% | -61.4% | -52.1% | -118.1% |
| Return on Assets (ROA) | -10.6% | -87.4% | -94.3% | -71.5% | -61.9% | -53.9% | -46.7% | -101.6% |
| Current Ratio | 128.41x | 8.98x | 7.93x | 6.94x | 10.83x | 10.47x | 13.07x | 7.63x |
| Quick Ratio | 123.49x | 5.38x | 2.62x | 3.23x | 5.46x | 5.89x | 7.82x | 7.47x |
| Debt to Equity | 0.00x | 0.06x | 0.04x | 0.04x | 0.01x | 0.01x | 0.01x | 0.03x |
| Revenue Growth (YoY) | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -- |
| EPS Growth (YoY) | +57.1% | +133.3% | +16.7% | -- | -12.5% | 0.0% | +20.0% | -- |